tbuckley/cabot-search huggingface dataset:
Circulating Tumor DNA Predicts Time to First Treatment in Previously Untreated Follicular Lymphoma: Analysis from a Prospective Clonal Evolution Study
Authors: Rahul Lakhotia, Stefania Pittaluga, James D. Phelan, Allison Graeter, Christopher Melani, Max J Gordon, Jagan R. Muppidi, Sam Y. Ng, Sumaya Berg, Sarah Evans, Amynah Pradhan, Atekelt Tadese, Candis Morrison, Bonita Bryant, Yandan Yang, Theresa Davies-Hill, Liza Lindenberg, Mark Ahlman, Esther Mena, Ethan Bergvall, Nick Micheletti, Laura M Yee, Allison P. Jacob, Monica Gallucci, Heidi Simmons, Alexander Bagaev, Mark Meerson, Ekaterina Postovalova, Olga Kudryashova, Nikita Kotlov, Nathan H. Fowler, Elaine S. Jaffe, Louis M. Staudt, Wyndham H. Wilson, Mark Roschewski
Journal: Blood (2024)
HLA-DQ8 Haplotype Increases the Risk of Relapse after Allogeneic Stem Cell Transplantation Possibly Affecting Graft-Versus-Leukemia: A Single-Center Study on 400 Patients
Authors: Giulia Losi, Annamaria Pasi, Carmen Tania Prezioso, Bianchessi Antonio, Caterina Zerbi, Irene Defrancesco, Anna Amelia Colombo, Francesco Romano, Valentina Da Prat, Alessia Taurino, Valentina Zoboli, Luca Arcaini, Cesare Perotti, Riccardo Caccialanza, Nicola Polverelli
Journal: Blood (2024)
A genome-wide association meta-analysis links hidradenitis suppurativa to common and rare sequence variants causing disruption of the Notch and Wnt/β-catenin signaling pathways
Authors: R Kjærsgaard Andersen, L Stefansdottir, P Theut Riis, Gh Halldorsson, E Ferkingstad, A Oddsson, G B Walters, Thorunn A Olafsdottir, G Rutsdottir, C Zachariae, S F Thomsen, T Brodersen, K M Dinh, K U Knowlton, S Knight, L D Nadauld, K Banasik, S Brunak, T F Hansen, H Hjalgrim, E Sørensen, C Mikkelsen, H Ullum, M Nyegaard, M T Bruun, C Erikstrup, S R Ostrowski, L Eidsmo, D M L Saunte, B Sigurgeirsson, K B Orvar, J Saemundsdottir, P Melsted, G L Norddahl, P Sulem, H Stefansson, H Holm, D Gudbjartsson, G Thorleifsson, I Jonsdottir, O B V Pedersen, G B E Jemec, K Stefansson
Journal: Journal of the American Academy of Dermatology (2024)
Treatment of First Relapse of Multiple Myeloma in Australia and New Zealand (ANZ): Treatment Patterns and Outcomes: An ANZ Myeloma and Related Diseases Registry (ANZ MRDR) Analysis
Authors: Betty Gration, Cameron Wellard, Elizabeth Moore, Marianne Tan, Matthew Murphy, Kenneth J C Lim, James Rowland, Nada Hamad, Rajeev Rajagopal, Peter Mollee, Andrew Spencer, Hang Quach, Georgia McCaughan
Journal: Blood (2024)
Randomized Phase 2 Dose Optimization Trial of Modakafusp Alfa in Relapsed/Refractory Multiple Myeloma (RRMM)
Authors: Shebli Atrash, Sarah A. Holstein, Hira Mian, Meletios A. Dimopoulos, Fredrik Schjesvold, Rakesh Popat, Nishi Shah, Moshe E Gatt, Christian B. Gocke, Laurent Frenzel, Cyrille Touzeau, Meral Beksac, Salomon Manier, Hila Magen, Patrick M. Travis, Omar Nadeem, Kaveri Suryanarayan, Shuli Li, Xavier Parot, Dan T. Vogl
Journal: Blood (2024)
Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States
Authors: Catherine J. Lee, Elizabeth M Hellewell, Kevin Ng, Ted Gooley, Anthony D. Sung, Allison O. Taylor, Sanghee Hong, Nausheen Ahmed, Cherie Morey, Sarah Fitzmaurice, Vanessa E. Kennedy, Michelle Lauer, Andrew D. Trunk, Betty K. Hamilton, Akshay Sharma, Zoey Phelps-Bergeron, LaQuisa Hill, Rawan Faramand, Hien Liu, Lena E Winestone, Geoffrey Cheng, Manuel Espinoza-Gutarra, Omer Jamy, Maria Odstrcil Bobillo, Brian McClune, Mariam T. Nawas, Samuel J. Yates, Miki Nishitani, Takuto Takahashi, Jane Koo, Kasiani Myers, Kris Michael Mahadeo, Andrea Bauchat, Laurie K Pearson, Ritika Walia, Kelsea Seago, Spencer Yingling, Cory Edgar, Amy Browning, Neel Bhatt
Journal: Blood (2024)
Unsupervised Analysis Applied to a Cohort of Likely Acquired Neutropenia: Is It a Unique Entity ?
Authors: Francesca Fioredda, Saba Kainat, Giacomo Cavalca, Mariacarla Giarratana, Gianluca Dell'Orso, Luca Arcuri, Paolo Uva, Davide Cangelosi, Carlo Dufour
Journal: Blood (2024)
Synergistic Activity of BMS-986397, a First-in-Class a Cereblon (CRBN) E3 Ligase Modulator (CELMoD) Targeting Casein Kinase 1α (CK1α), in Combination with Venetoclax and/or Azacitidine in Preclinical Models of Acute Myeloid Leukemia (AML)
Authors: Carmen Jimenez, Jose Francisco Lopez, Estela Garcia, Laura Diaz Regalado, Alejandro Panjkovich, Sophie Peng, Rama Krishna Narla, Noelia Purroy, Mark Rolfe, Daniel W. Pierce, Soraya Carrancio
Journal: Blood (2024)
Efficacy and Safety of a New Regime Containing PD1 Antibody and Pegaspargase for Advanced-Stage or Relapsed/Refractory Natural Killer/T Cell Lymphoma
Authors: Jie Chen, Linjun Zhao, Chongyang Wu, Haifeng Yu, Zhenling Li, Lihong Liu, Da Gao, Ying Sun, Xiaolei Wei, Yuanbin Wu, Yue Wang, Yuqin Song, Jun Zhu, Weiping Liu
Journal: Blood (2024)
Symptoms Detection Among Patients with Lymphoid Malignancies (LM) Using Electronic Patient-Reported Outcomes (ePROs) in Community Hematology-Oncology Clinics
Authors: James H Essell, Benjamin A Derman, Michael A. Kolodziej, Lavi Kwiatkowsky, Geoffrey Calkins, Christina M Parrinello, Mustafa S Ascha
Journal: Blood (2024)
Combination Therapy with Nelarabine, Peg-Asparaginase and Venetoclax for Adults Patients with Relapsed/Refractory T-Cell ALL
Authors: Niranjan Shiwaji Khaire, Elias Jabbour, Tapan M. Kadia, Nicholas J. Short, Gautam Borthakur, Naveen Pemmaraju, Naval Daver, Partow Kebriaei, Shilpa Paul, Vishrut Shah, Rebecca Garris, Koji Sasaki, Farhad Ravandi, Nitin Jain
Journal: Blood (2024)
Single-Center Retrospective Analysis of Autologous Stem Cell Transplantation for Patients with Systemic Light Chain Amyloidosis
Authors: Kodai Kunisada, Taku Kikuchi, Nobuhiro Tsukada, Tomomi Takei, Moe Yogo, Kota Sato, Mizuki Ogura, Yu ABE, Kenshi Suzuki, Tadao Ishida
Journal: Blood (2024)
Single-Cell Transcriptomic Analysis of Bone Marrow from Humanized Sickle Cell Mice Reveals a Subpopulation of Highly-Expressing S100A8/A9 Mesenchymal Stem Cells
Authors: Jacopo Ceolan, Petros Kolovos, Enrica Federti, Panagiotis Liakopoulos, Veronica Riccardi, Immacolata Andolfo, Alessandro Mattè, Roberta Russo, Achille Iolascon, Helene Gleitz, Sjaak Philipsen, Lucia De Franceschi
Journal: Blood (2024)
Donor T-Derived Memory Progenitors Differentiated into CD103+/- CXCR6+CD4+ Tissue-Resident T Cell Subsets Driven Cutaneous Chronic Graft-Versus-Host Disease
Authors: Xiaohui Kong, Bixin Wang, Xiwei Wu, Weijia Fu, Qinjian Li, Moqian Zheng, Raju Pillai, Ryotaro Nakamura, Paul J. Martin, Defu Zeng
Journal: Blood (2024)
Short and Long-Term Toxicities of Allogeneic Stem Cell Transplant for Adult Patients with Sickle Cell Disease
Authors: Mazin Mohamed Abdulsalam, Bader Alahmari, Ahmed Alaskar, Ayman Alhejazi, Abdullah AlSaleh, Husam Mazin Alsadi, Mohammed Bakkar, Abdulrahman Al Raizah, Hind Salama, Ayman Ibrahim, Ayel Yahya, Sumaya Altamimi, Khalid Aldosari, Abdul Rauf Ghori, Afnan Alnajjar, Khalid Alharbi, Nahla Wahby, Mohammed Ali, Inaam Shehabeddine, Rasha Ahmed, Tahani Alanazi, Isam Mahasneh, Suha Alkhraisat, Hamza Alquraan, Amani Alharbi, Afnan Alzaidi, Eman Anizi, Norah Alshuraym, Maybelle Ballili, Mohsen Alzahrani
Journal: Blood (2024)
Prognosis of the IGLV3-21R110 Mutation in a Real-Life Chronic Lymphocytic Leukemia Cohort
Authors: Merieme Bensalah, Amal Messaoudi, Carole Fleury, Giulia Tueur, Rémi Letestu, Marine Armand, Sabine Brechignac, Sarah Ivanoff, Valérie Vidal, Ramy Rahmé, Chadi Al Nawakil, Thorsten Braun, Catherine Thieblemont, Cymbalista Florence, Vincent Levy, Fanny Baran-Marszak, Grégory Lazarian
Journal: Blood (2024)
A Phase 2 Clinical Trial of Anti-CD19 CAR-T (pCAR-19B) in Chinese Pediatric and Young Adult with Relapsed/Refractory (R/R) CD19+ B-ALL: The First Pivotal Study in an Asian Population
Authors: Ruidong Zhang, Yang Cao, Xiaofan Zhu, Zhenya Hong, Jianwen Xiao, Fei Li, Ju Gao, Hongling Peng, Yongmin Tang, Runming Jin, Sixi Liu, Yajuan Cui, Shaoyan Hu, Min Yu, Xiaojun Xu, Xiaoyan Wu, Xiaoxi Lu, Huirong Mai, Xiaoxi Zhou, Yingzi Zhang, Zhi Yang, Yufeng Huang, Xiao He, Liang Huang, Cheng Qian, Yicheng Zhang, Tianyou Wang
Journal: Blood (2024)
Fixed-Duration Epcoritamab + R-Mini-CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Ineligible for Full-Dose R-CHOP: Updated Results from Arm 8 of the Epcore NHL-2 Trial
Authors: Lori A. Leslie, Chan Y. Cheah, Franck Morschhauser, Justin M. Darrah, Joshua Brody, David Belada, Juraj Duras, Joost S.P. Vermaat, Gerardo Musuraca, Kojo Osei-Bonsu, Yi Hao, Kimberly G. Archer, Monica Wielgos-Bonvallet, Ali Rana, Yasmin H. Karimi
Journal: Blood (2024)
Initial Results of a Phase 1 First-in-Human Study of Cemsidomide (CFT7455), a Novel MonoDACTM Degrader, with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
Authors: Binod Dhakal, Andrew J. Yee, Paul G. Richardson, Sikander Ailawadhi, Saurabh Chhabra, Eli Muchtar, Jesús G. Berdeja, Shambavi Richard, Jeffrey V Matous, Urvi A. Shah, Mark A. Schroeder, Amro Ali, Leah Leahy, Riadh Lobbardi, Rong Chu, Eunju Hurh, Anthony S. Fiorino, Sagar Lonial
Journal: Blood (2024)
Inhibition of Purine Nucleoside Phosphorylase Is a Promising Anti-Sickling Approach for Sickle Cell Disease
Authors: Adekunle Emmanuel Alagbe, Lynda Little-Ihrig, Brian J Philips, Stephanie M Mutchler, Julia Z Xu, Edwin K Jackson, Stevan Tofovic, Enrico M Novelli
Journal: Blood (2024)
<i>Discovery of Undocumented, Cancer-Specific and Pro-Inflammatory Isoforms of WNK2 That Are Highly Expressed in MYD88 Mutated Waldenström's Macroglobulinemia and Represent Novel Therapeutic Targets.</i>
Authors: Maria Luisa Guerrera, Xia Liu, John M Hatcher, Nickolas Tsakmaklis, Amanda Kofides, Abigail Peachey, Hao Sun, Shirong Liu, Christopher J Patterson, Eugenio Morelli, Jorge J. Castillo, Shayna R Sarosiek, Catherine A. Flynn, Kirsten Meid, Andrew R. Branagan, Ruben D. Carrasco, Kenneth C. Anderson, Nikhil C. Munshi, Steven P. Treon, Zachary R Hunter
Journal: Blood (2024)
In Vitro and In Vivo Activity of a Lipid Nanoparticle System for the In Vivo Generation of CAR T Cells
Authors: Viktor Lemgart, Jennifer Richards, Laura Strauss, Jing Jiao, Brandon Quido, Laura Powers, Allison Caron, Eyoung Shin, Austin Boesch, Dharini Shah, Tiffany Le, Rasika Kunden, Samantha Stewart, Fazila Nasimi, Sampa Maiti, Mir Ali, Olga Lihoradova, Aaron Griset, Christopher M. Borges, William Kuhlman, Carla Lawendowski, Ulrik Nielsen, Valeria Fantin, Daryl Drummond, Donald Shaffer, Andrew J Sawyer
Journal: Blood (2024)
Real-World Predictors of Financial Toxicity in Patients with Lymphoma
Authors: Syeda A Mina, Katherine E Smith, Ashley D Hickman, Melissa C. Larson, Brianna J Negaard, Brittany C Kimball, Matthew J. Maurer, Kathleen J Yost, Grzegorz S. Nowakowski, Izidore S. Lossos, Peter Martin, Jonathon B. Cohen, Brian K. Link, Brad S. Kahl, Loretta Nastoupil, James R. Cerhan, Christopher R. Flowers, Amylou C Dueck, Annalynn M Williams, Carla Casulo, Carrie A Thompson, Urshila Durani
Journal: Blood (2024)
M-Easix (Better Than EASIX) Correlates with Specific Endotheliopathy Biomarkers, Predicts Severe CAR-T Cell Toxicities and Discriminates from Sepsis
Authors: Ana Belén Moreno-Castaño, Sara Fernández, Helena Brillembourg, Blanca de Moner, Helena Ventosa-Capell, Julia Martinez-Sanchez, Alex Ramos, Marta Palomo, Patricia Molina, Marc Pino, Pilar Gomez-Ramirez, Valentin Ortiz-Maldonado, Nuria Martínez-Cibrián, Julio Delgado, Carlos Fernández de Larrea, Maria Queralt Salas Gay, Alvaro Urbano-Ispizua, Adrián Téllez, Jose Maria Nicolas, Ginés Escolar, Enric Carreras, Francesc Fernández-Avilés, Pedro Castro, Maribel Diaz-Ricart
Journal: Blood (2024)
Multi-Omics Profiling Reveals Tumor Cellular Landscape and Metabolism Remodeling during Extranodal Natural Killer/T-Cell Lymphoma (ENKTL) Metastasis and Progression
Authors: Jinhua Liang, Kai-Xin Du, Yue Li, Tong-Yao Xing, Hao-Rui Shen, Jiazhu Wu, Hua Yin, Li Wang, Jianyong Li, Xu Wei
Journal: Blood (2024)
Ezh2 and Intracellular Ca2+ Signals Interdependently Coordinate Gvhd and CAR T Cell Responses
Authors: Ying WANG, Qingrong Huang, Ruqayyah sanders-Braggs, Yan Zhou, Robert Hooper, Yuanyuan Tian, Tatiana Kent, Richard Pomerantz, Gennaro Clando, Jean-Pierre Issa, Jonathan Soboloff, Yi Zhang
Journal: Blood (2024)
Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma with Stable or Progressive Disease
Authors: Kimimori Kamijo, Yoshimitsu Shimomura, Naoyuki Uchida, Satoshi Yoshihara, Takahiro Fukuda, Yasufumi Uehara, Yasuo Mori, Tetsuya Eto, Hikaru Kobayashi, Kentaro Serizawa, Tatsuo Ichinohe, Makoto Yoshimitsu, Junya Kanda, Yoshiko Atsuta, Shinichi Kako
Journal: Blood (2024)
Real-World Bruton Tyrosine Kinase Inhibitor (BTKi) Utilization and Clinical Outcomes Among Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Authors: Jing-Zhou Hou, Rushir Choksi, Gregory A. Maglinte, Anupama Vasudevan, Anna Rui, Brandon Wang, Hoa Pham, Ann Lasn, Simon Blanc
Journal: Blood (2024)
Targeting the PI3K/AKT Pathway and Fatty Acid Synthase in AL Amyloidosis: Mechanistic Insights and Therapeutic Implications
Authors: Tal Zvida-Bloch, Eli Muchtar, Mali Salmon-Divon, Angela Dispenzieri, Benjamin Bender, Adrian Duek, Merav Leiba, Moshe E Gatt, Ofer Shpilberg, Oshrat Hershkovitz-Rokah
Journal: Blood (2024)
Potent Target-Specific Efficacy of CAR T Cells Directed Toward the AML and KMT2A-Rearranged Specific Antigen CLEC2A
Authors: Danielle C. Kirkey, Grace Hawkins, Melia Blankenfeld, Isabel Lira, Nika Panahi, Margaret G Hines, Seungmin Shin, Tiffany Hylkema, Cyd McKay, Christina Root, Logan K. Wallace, Jack H. Peplinski, Rhonda E. Ries, Concetta Quintarelli, Franco Locatelli, Wei Li, Soheil Meshinchi
Journal: Blood (2024)
CAR-T Cell Subsets and Immune Repertoire Are Associated with Immune-Related Adverse Events and Efficacy after CD19 CAR T-Cell Therapy in B Cell Lymphoma
Authors: David M Foureau, Fei Guo, Erik Broemsen, Tahj Jones, Anna Ivanina-Foureau, Ryan Jacobs, Bei Hu, Tamara K Moyo, Yifan Pang, Steven I. Park, Lawrence J. Druhan, Ariel Bell, Nilanjan Ghosh
Journal: Blood (2024)
Dose Optimization of Check-Point Inhibitors: A Comparison of Standard Dose and Low Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma
Authors: Chirag Trivedi, Sujith Kumar, Sushil Selvarajan, Sharon Anbumalar Lionel, Anup J Devasia, Fouzia N., Uday Kulkarni, Aby Abraham, Alok Srivastava, Biju George, Vikram Mathews, Anu Korula
Journal: Blood (2024)
A Phase 1 Study of the Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
Authors: Yesid Alvarado-Valero, Rachel J. Cook, Shira N. Dinner, Michael Keng, Kebede Begna, Sameem Abedin, MHD Monzr M. Al Malki, Vijaya Raj Bhatt, Nathalie Javidi-Sharifi, Prabhu Rajagopolan, Sandra Wiley, Richard G Ghalie, Matthew S. Davids
Journal: Blood (2024)
HPK1 Inhibition and Venetoclax Combination Suppressed AML By Enhancing Cytotoxic T-Cell Response to Leukaemia
Authors: Xiaoyuan Zeng, Kwui-Wa Tong, Koon Chuen Chan, Li-Chuan Zheng, Stephen Lam, Mark Robert Bray, Tak-Wah Mak, Cheuk-Him Man, Anskar Y. H. Leung
Journal: Blood (2024)
Genome-Wide Meta-Analysis Identifies Multiple Germline Genetic Variants Associated with Increased Risk of Follicular Lymphoma
Authors: Vijai Joseph, Alyssa I Clay-Gilmour, Hanla Park, Charles Breeze, Lara E. Sucheston-Campbell, Joshua Arias, Rosalie Griffin Waller, Murat Güler, Alexandra Nieters, Karin Ekstroem Smedby, Ólafur Birgir Davídsson, Sophia S. Wang, Qing Lan, Henrik Hjalgrim, Susan L. Slager, James McKay, James R. Cerhan, Sonja I. Berndt, Nathaniel Rothman
Journal: Blood (2024)
Secondary Cancers Among Patients with Multiple Myeloma: A 15-Year Analysis of a Population-Based Cohort in Ontario, Canada
Authors: Alissa Visram, Rajshekhar Chakraborty, Gregory R Pond, Hsien Seow, Anastasia Gayowsky, Ghulam Rehman Mohyuddin, Samer Al Hadidi, Alejandro Garcia-Horton, Rafael Fonseca, Hira Mian
Journal: Blood (2024)
Effects of Splenomegaly in Children with Sickle Cell Anemia Treated with Hydroxyurea: Secondary Analysis of the Sphere Trial
Authors: Emmanuela Eusebio Ambrose, George A. Tomlinson, Patrick S. Ngoya, Susan E. Stuber, Teresa S. Latham, Abel Nkono Makubi, Russell E. Ware, Luke R. Smart
Journal: Blood (2024)
Clinical Outcomes Using Frontline “Triplet” Regimens for Newly Diagnosed <i>IDH</i>-Mutated Acute Myeloid Leukemia (AML): A Pooled Analysis of Two Phase Ib/2 Clinical Trials
Authors: Jennifer Marvin-Peek, Himachandana Atluri, Nicholas J. Short, Abhishek Maiti, Koichi Takahashi, Sanam Loghavi, Curtis A Lachowiez, Yesid Alvarado Valero, Guillermo Montalban-Bravo, Koji Sasaki, Fadi G. Haddad, Ghayas C. Issa, Lucia Masarova, Hussein A. Abbas, Michael Andreeff, Gautam Borthakur, Jillian Mullin, George Donovan Tippett, Kelly S. Chien, Danielle Hammond, Jo Ishizawa, Nitin Jain, Patrick K. Reville, Mahesh Swaminathan, Musa Yilmaz, Naval Daver, Tapan M. Kadia, Farhad Ravandi, Guillermo Garcia-Manero, Hagop M. Kantarjian, Courtney D. DiNardo
Journal: Blood (2024)
Real-World Outcomes of Polatuzumab Vedotin with Bendamustine and Rituximab As Salvage and Bridge Therapy to CAR T-Cell Treatment in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Authors: Changgon Kim, SangEun Yoon, Hyun-Young Kim, Duck Cho, Hong Hoe Koo, Junhun Cho, Won Seog Kim, Seok Jin Kim
Journal: Blood (2024)
Uncovering the Epidemiology, Therapy Patterns and Outcomes of MALT Lymphoma in Latin America: A Multinational Retrospective Cohort Study
Authors: Monica Labrano Elias, Seisha Von Glasenapp, Carlos Chiattone, Sergio Augusto B Brasil, Brady Beltran, Denisse Castro, Sally Paredes, Ana Carolina Oliver, Victoria Irigoin, Sabrina Ranero Ferrari, Virginia Lema Spinelli, Carla Ambrosoni, Gimena Dos Santos, Marta Elisa Zerga, Sofía Gabriela Rivarola, German R. Stemmelin, Fernando Warley, Fabiola Valvert, Julio D Fernández Águila, Rosa Oliday, Macarena Roa, Camila Peña, Javier Melo, Maria Lucia Fonseca Bolanos, Luis Mario Villela Martinez, Arianna Robles Rodriguez, Juan Francisco Zazueta Pozos, Gerardo Santigo Jimenez, Alonso Hernandez, Marialejandra Torres Viera, Marcos Hernandez, Henry Quintero, Jose Marcial Macias Abasto, Maria Panozo, Bryan Valcarcel, Luis Enrique Malpica Castillo
Journal: Blood (2024)
Survival Analysis of Gimema AML1718, a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia
Authors: Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, Cristina Papayannidis, Fabio Guolo, Marco Cerrano, Valentina Arena, Saveria Capria, Michela Rondoni, Matteo Giovanni Della Porta, Germana Beltrami, Monica Bocchia, Albana Lico, Luisa Giaccone, Marianna Rossi, Catello Califano, Matteo Giovanni Carrabba, Chiara Cattaneo, Marco Frigeni, Maria Chiara Di Chio, Bianca Serio, Roberto Freilone, Antonio Curti, Paola Minetto, Giovanni Marsili, Clara Minotti, Beatrice Anna Zannetti, Francesca Cotugno, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Sara Rosellini, Elisabetta Tedone, Adriano Venditti, Roberto Massimo Lemoli, Marco Vignetti, Paola Fazi, Giovanni Martinelli
Journal: Blood (2024)
Immunoglobulin Sequencing Biologically Distinguishes B-Lymphoblastic Lymphoma from Acute Lymphoblastic Leukemia and Reveals a Spectrum of Disease Dissemination across Clinical Stages
Authors: Carol Fries Simpson, Lik Wee Lee, Hongyue Wang, Diana G. Adlowitz, Philip Rock, Brent L. Wood, Rachel E. Rau, Kara L. Davis, Anne Angiolillo, Meenakshi Devidas, David T. Teachey, Karen R Rabin, Birte Wistinghausen, Donald Barkauskas, Robert J. Hayashi, Richard Burack, Carl E Allen, Michelle L. Hermiston, Ilan R. Kirsch
Journal: Blood (2024)
TQB2223 in Combination with Penpulimab in Patients with Relapsed or Refractory Lymphoma: Primary Analysis of an Open-Label Phase I Study
Authors: Qingqing Cai, Yi Xia, Xiaojie Fang, Man Nie, Qihua Zou, Jun Cai, Yuchen Zhang, Qiuyi Yang, Dawei Ding, Wen Wang, Xunqiang Wang
Journal: Blood (2024)
Inhibition of the Complement Alternative Pathway Attenuates Hemolysis and Preserves Renal Function in a Mouse Model of Sickle Cell Disease
Authors: Thiago Trovati Maciel, Nabiha Sbeih, Rachel Rignault-Bricard, Isabelle Chevalme, Slimane Allali, Camille Brochier, Anna Kiialainen, Tovo David, Olivier Hermine
Journal: Blood (2024)
Outcomes of Patients with Multiple Myeloma with Deletion 1p Following Autologous Stem Cell Transplant
Authors: Oren Pasvolsky, Denái R. Milton, Mark R. Tanner, Qaiser Bashir, Samer A. Srour, Neeraj Y. Saini, Paul Lin, Ashka Patel, Hina N. Khan, Jeremy Ramdial, Yago Nieto, Guilin Tang, Asad Haider, Yosra M. Aljawai, Saqib Ahmed, Partow Kebriaei, Hans C. Lee, Christine Ye, Krina K. Patel, Sheeba K. Thomas, Robert Z. Orlowski, Richard E. Champlin, Elizabeth J. Shpall, Muzaffar H. Qazilbash
Journal: Blood (2024)
M2-like Macrophages Transfer Mitochondria to Acute Myeloid Leukaemia Cells Via Tunnelling Nanotubes Promoting Therapy Resistance
Authors: Ebubechukwu Nwarunma, Katerina Miari, Athanasia Papadopoulou, Leandro Martinez, Victoria Campbell, Samantha Hurwitz, Tatiana Fourfouris, Ki Jun Lee, Carl Goodyear, Theodoros Simakou, Marcus Doohan, Lucy MacDonald, Timothy Humpton, Lesley Forrester, Mariola Kurowska-Stolarska, Ken I Mills, Yong-Mi Kim, Helen Wheadon, Monica L Guzman, Mark T Williams
Journal: Blood (2024)
Upfront Use of Anti-CD38 Monoclonal Antibodies Is Associated with Improvement in Renal Failure in Multiple Myeloma: A Flatiron Real World Analysis from 2010 to 2023
Authors: Adeel M Khan, Zimu Gong, Tanushree Prasad, Rahul Banerjee, Srija Shankar, Aimaz Afrough, Larry D Anderson, Meera Mohan, Gurbakhash Kaur
Journal: Blood (2024)
Characteristics and Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A 14-Year Experience in a Limited Resource Setting
Authors: Abeer Yaseen, Mohammad Ma'koseh, Albatol Alamoush, Anas Zayed, Mona Ribie, Marah Alzubi, Jawad Alrawabdeh, Rozan Alfar, Waleed Kamel Da'Na, Salwa Shihadeh Saadeh, Yazan Talab, Husam Abu Jazar, Samer Al-Hadidi, Sameer Yaser, Zaid Abdel Rahman
Journal: Blood (2024)
Real-World Comparison of Outcomes of Patients Treated with HMA Monotherapy Versus HMA-Ven - Insights from 1634 Patients Included within the Austrian Myeloid Registry of the AGMT Study Group
Authors: Lisa Pleyer, Patrick Klammer, Manuel Drost, Hubert Angermann, Felix Keil, Verena Petzer, Sonja Heibl, Jennifer Moritz, Michael Girschikofsky, Margarete Stampfl-Mattersberger, Angelika Pichler, Bernd L. Hartmann, Gregor Aschauer, Clemens Schmitt, Sonia Vallet, Szilvia Boros, Petra Pichler, Andrea Hammerl-Steiner, Felix Renneberg, Susanne Schnabel, Dilyan Majjiga, Thomas Melchardt, Alexander Egle, Michael Leisch, Richard Greil
Journal: Blood (2024)
A Real-World Analysis of the Safety and Efficacy of BCMA-Directed CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment
Authors: Alma Habib, Nausheen Ahmed, Abdullah Mohammad Khan, Darryl Chang, Barry Paul, Hira Shaikh, Christopher Strouse, Emily Struble, Andrew Vegel, James A Davis, Kimberly M Green, Hamza Hashmi, Zahra Mahmoudjafari, Muhammad Umair Mushtaq, Joseph P. McGuirk, Al-Ola Abdallah, Shebli Atrash, Reed Friend
Journal: Blood (2024)
Combination of Olutasidenib and Azacitidine Induces Durable Complete Remissions in m<i>IDH1</i> Acute Myeloid Leukemia: A Multicohort Open-Label Phase 1/2 Trial
Authors: Jorge E. Cortes, Gail J. Roboz, Justin M. Watts, Maria R. Baer, Brian A. Jonas, Gary J. Schiller, Karen Yee, Brent Ferrell, Jay Yang, Eunice S. Wang, William Blum, Alice Mims
Journal: Blood (2024)
Molecular Features of Acute Myeloid Leukemia in Hispanics: An Analysis from the Marrow Consortium
Authors: Jesus D Gonzalez-Lugo, Yazan F Madanat, Nidia Zapata, Deedra Nicolet, Victoria Klein, Charles Foucar, Krzysztof Mrózek, Nicole Twardowski, Sharlene Dong, Haitham Abdelhakim, Ana Varela Constantino, Judith Cruz Velazquez, Diana Arcos, Angelica Santiago Medina, Jose Ramiro Espinoza Zamora, Alice Mims, Tara L. Lin, Ann-Kathrin Eisfeld, Onyee Chan, Andres Gomez-De Leon
Journal: Blood (2024)